Advertisement

Topics

LORELEI trial of letrozole and taselisib for ER positive breast cancer

07:23 EDT 11 Sep 2017 | ecancermedicalscience

Dr Saura speaks with ecancer at ESMO 2017 about the results of the LORELEI trial, in which women with ER positive, HER2 negative advanced breast cancer were treated with a combination of letrozole and taselisib. Dr Saura describes the pathways and...

Original Article: LORELEI trial of letrozole and taselisib for ER positive breast cancer

NEXT ARTICLE

More From BioPortfolio on "LORELEI trial of letrozole and taselisib for ER positive breast cancer"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...